As part of our ongoing aim to bring you reports of interesting new studies, we have added a review of results from the EINSTEIN CHOICE study, a clinical trial that compared the efficacy and safety of rivaroxaban with those of aspirin in patients with venous thromboembolism.
Independent expert commentary is provided by Professor Chris Ward, a Haematologist at Royal North Shore Hospital with clinical and research interests in coagulation and platelet biology.
Please login below to download this issue (PDF)